文献速递眼底病与葡萄膜炎

六氟化硫与全氟丙烷气体作为黄斑裂孔手术填充物的比较

SULFURHEXAFLUORIDE (SF6) VERSUS PERFLUOROPROPANE (C3F8) GAS AS TAMPONADE IN MACULAR HOLE SURGERY.
PubMed 文献 · Retina · 2017-01-01

回顾性比较研究纳入177只眼(166例患者)特发性黄斑裂孔手术,67只眼用六氟化硫(SF6)填充,111只眼用全氟丙烷(C3F8)填充。两组裂孔闭合率相似(86.4% vs 86.5%,P=0.98),但C3F8组眼压升高更明显、白内障进展更多(83.3% vs 73.9%,P=0.20)。作者认为C3F8或可作为初次手术失败后的首选眼内填充剂。

要点

  • SF6与C3F8填充术后黄斑裂孔闭合率相似(86.4% vs 86.5%,P=0.98)。
  • C3F8组眼压升高更明显(P<0.05),白内障进展比例更高但未达统计学显著(83.3% vs 73.9%,P=0.20)。
  • 再次手术中C3F8与SF6再注射的闭合率分别为3/4(75%)和1/5(20%)。

核心结论

  • 六氟化硫与全氟丙烷的黄斑裂孔闭合率相似,与裂孔大小、分期或病程无关。
  • 六氟化硫的白内障和眼压升高发生率较低,填充持续时间较短。
  • 作者认为全氟丙烷或可作为初次手术失败后的首选眼内填充剂。

研究设计与样本

  • 回顾性、干预性、比较性研究,纳入3年期间手术的166例患者共177只眼特发性黄斑裂孔。
  • 67只眼使用六氟化硫(SF6)填充(第1组),111只眼使用全氟丙烷(C3F8)填充(第2组)。
  • 主要结局指标为黄斑裂孔闭合率,统计分析使用SPSSv16。

主要发现

  • 基于谱域光学相干断层扫描的黄斑裂孔分期分布在两组间相似(P=0.99)。
  • 裂孔闭合率:SF6组57/66(86.4%),C3F8组96/111(86.5%)(P=0.98)。
  • 亚组分析显示,裂孔大小、分期或病程方面闭合率均无显著差异。
  • 最佳矫正视力平均提高:SF6组0.28 logMAR(P=0.00),C3F8组0.42 logMAR,分别对应早期治疗糖尿病视网膜病变研究视力表上3行和4行提高(P<0.05),组间差异不显著(P=0.06)。
  • C3F8组眼压升高更明显(P<0.05);白内障进展C3F8组83.3% vs SF6组73.9%,但无统计学显著差异(P=0.20)。

关键数值与推荐

  • 裂孔闭合率SF6组57/66(86.4%)vs C3F8组96/111(86.5%)(P=0.98)。
  • 最佳矫正视力提高SF6组平均0.28 logMAR(P=0.00)vs C3F8组平均0.42 logMAR,组间差异不显著(P=0.06)。
  • 白内障进展SF6组73.9% vs C3F8组83.3%(P=0.20)。
  • 再次手术共9/177只眼;C3F8再注射闭合率3/4(75%),SF6再注射闭合率1/5(20%)。
  • 再次手术后解剖闭合:第1组4/5只眼,第2组0/4只眼。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare outcomes of macular hole surgery using sulfurhexafluoride (SF6) versus perfluoropropane (C3F8) gas. METHODS: This is a retrospective, interventional, comparative study. A total of 177 eyes of 166 patients operated over a 3-year period for idiopathic macular holes were included. Sixty-seven eyes had tamponade with SF6 gas (Group 1), whereas 111 eyes received C3F8 (Group 2) as the tamponading agent. The primary outcome measure was the macular hole closure rate. Statistical analysis was done using SPSSv16. RESULTS: Spectral domain optical coherence tomography-based stagewise distribution of macular holes were similar across both groups (P = 0.99). The hole closure rate was 57/66 (86.4%) with SF6 and 96/111 (86.5%) with C3F8 gas (P = 0.98). Subanalysis demonstrated no significant difference in closure rates regarding macular hole size, stage, or duration. Best-corrected visual acuity improved by a mean of 0.28 logMAR in the SF6 group (P = 0.00) and 0.42 logMAR in the C3F8 group, corresponding to 3 lines and 4 lines of improvement, respectively, on the Early Treatment Diabetic Retinopathy Study chart (P < 0.05). The difference was not significant (P = 0.06). Rise in intraocular pressure was higher in the C3F8 group (P < 0.05). Progression of cataract was also greater in the C3F8 group (83.3 vs.73.9%), but it was not statistically significant (P = 0.20). Resurgery was done in 9/177 eyes. The closure rate with C3F8 and SF6 reinjections was 3/4 (75%) and 1/5 (20%). Moreover, anatomical hole closure after resurgeries was better in Group 1 (4/5 eyes) than in Group 2 (0/4 eyes). CONCLUSION: The macular hole closure rate was similar with sulfurhexafluoride and perfluoropropane, irrespective of hole size, stage, or duration. However, sulfurhexafluoride exhibited a decreased incidence of cataract and ocular hypertension with shorter tamponade duration. Perfluoropropane may have a role as the preferred endotamponading agent in failed primary surgeries.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Modi A, Giridhar A, Gopalakrishnan M, et al. SULFURHEXAFLUORIDE (SF6) VERSUS PERFLUOROPROPANE (C3F8) GAS AS TAMPONADE IN MACULAR HOLE SURGERY. Retina. 2017. PMID: 28118283. doi:10.1097/IAE.0000000000001124

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。